{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "Y",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "NOM",
      "openfda": {
        "k_number": [
          "K243496",
          "K093678",
          "K023857",
          "K060641"
        ],
        "registration_number": [
          "8023060",
          "3035708936",
          "3022929618"
        ],
        "fei_number": [
          "3003992026",
          "3035708936",
          "3022929618"
        ]
      },
      "review_panel": "MI",
      "medical_specialty": "MI",
      "device_name": "Antigen, Galactomannan, Aspergillus Spp.",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Microbiology",
      "device_class": "1",
      "definition": "The Platelia Aspergillus EIA is an immunoenzymatic sandwich microplate assay for the detection of Aspergillus galactomannan antigen in human serum.    It is a test which, when used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples and radiographic evidence, can be used as an aid in the diagnosis of Invasive Aspergillosis.",
      "regulation_number": "866.3040",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}